Risk Factors for Bronchopulmonary Dysplasia in very Low Birth Weight Newborns Treated with Mechanical Ventilation in the First Week of Life

Manktelow BN, Draper ES, Annamalai S, Field D. Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992 and 1997. Arch Dis Child Fetal Neonatal2001; 85: 33–5.

Egreteau L, Pauchard JY, Semama DS, Matis J, Liska A, Romeu B, et al. Chronic oxygen dependency in infants born at less than 32 weeks gestation: incidence and risk factors. Pediatrics2001; 108: 1–8.

Young TE, Kruyer L, Marshall DD, Bose CL, and the North Carolina Neonatologist Association. A population-based study of chronic lung disease in very low birth weight in North Carolina in 1994, with comparisons to 1984. Pediatrics1999; 104(2).URL; http://www.pediatrics.org/cgi/content/full/104/2/e17.

Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med2001; 163: 1723–9.

Corcoran JD, Patterson CC, Thomas PS, Halliday HL. Reduction in the risk of bronchopulmonary dysplasia from 1980–1990: results of a multivariate logistic regression analysis. Eur J Pediatr1993; 152: 667–81.

Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, et al. Do clinical markers of barotrauma and toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics2000; 105: 1195–201.

Todd DA, Jana A, John E. Chronic oxygen dependency in infants Born at 24–32 weeks gestation: the role of antenatal and neonatal factors [abstract]. J Paediatr Child Heath1997; 33: 402–7.

Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O’Shea M, and the North Carolina Neonatologist Association. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics1999; 104: 1345–50.

Van Marter LJ, Leviton A, Kuban KCH, Pagano M, Allred EN. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics1990; 86: 331–6.

Garland JS, Buck RK, Allred EN, Leniton A. Hipocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med1995; 149: 617.

Bancalari E, Abnenour GE, Feller R, Gannon J. Bronchopulmonary Dysplasia: clinical presentation. J Pediatr1979; 95: 819.

Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr1991; 119: 417–23.

Skov T, Deddens J, Petersen MR, Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol1998; 27: 91–5.

Hosmer DW, Lemeshow SL. Applied logistic regression. New York: Wiley; 1989; p.307.

Cunha GS, Mezzacappa FF, Ribeiro JD. Maternal and neonatal factors affecting the incidence of bronchopulmonary dysplasia in very low birth weight newborns. J Pediatr2003; 79(6): 550–56.

Collaborative Neocosur Multicenter Study Group. Very low birth weight infant outcomes in 11 South American NICUs. J Perinatol2002; 22: 2–7.

Lee SK, McMillan DD, Ohlsson A. Variations in practice and outcomes in the Canadian NICU Network 1996–1997. Pediatrics2000; 106: 1070–9.

Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics2001; 107(1). Available at: http://www.pediatrics.org/cgi/content/full/107/l/el.

Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Méd1967; 276: 357–68.

Bancalari E, Moral TD. Bronchopulmonary dysplasia and surfactant. Biol Neonate2001; 80: 7–13.

Horbar JD, Soll RF, Sutherland JM. A multicenter randomized placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med1989; 320: 959–65.

Liechty EA, Donovan E, Purohit D, Gilhooly J, Feldman B, Nogochi A. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics1991; 88: 19–28.

Palta M, Gabbbert D, Weinstein MR, Peters ME. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J Pediatr1991; 119: 285–92.

Fenton AC, Mason E, Clarke M, Field DJ. Chronic lung disease following neonatal ventilation II: changing incidence geographically defined population. Pediatr Pulmonol1996; 21: 24–7.

Korhonen P, Tammela O, Koivisto AM, Laippala P, Ikonen S. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev1999; 54: 245–58.

Van Marter LJ, Pagano M, Allred EN, Leviton A, Kuban KCK. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr1990; 116: 942–9.

Van Marter LJ, Pagano M, Allred EN, Leviton A, Kuban KCK. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. Fetal and Neonatal Medicine1992; 120: 938–46.

Bancalari E, Claure N, Sosenko IRS. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Seminars in Neonatology2003; 8: 63–71.

Tammela OKT, Koivisto ME. Fluid retriction for preventing bronchopulmonary dysplasia? Reduced fluid intake during the first weeks of life improve the outcome of low-birth weight infants. Acta Paediatr1992; 81: 207–12.